Results 131 to 140 of about 1,232 (160)
Some of the next articles are maybe not open access.
The controversy surrounding indomethacin for tocolysis
American Journal of Obstetrics and Gynecology, 2001Indomethacin is a prostaglandin synthetase inhibitor sometimes used for tocolysis. Several placebo-controlled trials and trials comparing indomethacin to other potential first-line tocolytic agents support its efficacy for delaying delivery for >48 hours.
David Michael Stamilio +5 more
openaire +3 more sources
Risks and Complications of Tocolysis
Clinical Obstetrics and Gynecology, 1995In this article, the author has reviewed available information on maternal, fetal, and neonatal risks and complications of tocolytic therapy. Because no ideal tocolytic agent exists, clinicians must be aware of the potential problems that can be encountered from initiating tocolysis.
openaire +2 more sources
Hemodynamic effects of nifedipine tocolysis
Journal of Obstetrics and Gynaecology Research, 2014AbstractAimTo describe the effects of nifedipine tocolysis on blood pressure and heart rate in non‐hypertensive women.MethodsThis was a retrospective study from 2001 to 2011 to compare blood pressures and heart rates among non‐hypertensive women on nifedipine tocolysis up to 8 h after nifedipine initiation.
Bliss Kaneshiro +2 more
openaire +3 more sources
The present and future of tocolysis
Best Practice & Research Clinical Obstetrics & Gynaecology, 2007This chapter discusses the tocolytic agents currently in use for the treatment of preterm labour and considers them in light of the evidence base. These agents are the β2 sympathomimetic agonists, magnesium sulphate (MgSO 4 ), indomethacin, nifedipine and atosiban. The available evidence for these agents shows that the β2 agents are effective but have
Warwick B. Giles, Andrew Bisits
openaire +2 more sources
Current Opinion in Obstetrics and Gynecology, 2004
There is persisting controversy about tocolytic treatment for preterm labour. This review addresses this controversy by appraising the recent clinical literature.Surveys of obstetricians indicate a high usage of tocolysis for preterm labour, but evidence that this treatment confers overall benefit is still lacking.
openaire +2 more sources
There is persisting controversy about tocolytic treatment for preterm labour. This review addresses this controversy by appraising the recent clinical literature.Surveys of obstetricians indicate a high usage of tocolysis for preterm labour, but evidence that this treatment confers overall benefit is still lacking.
openaire +2 more sources
BMJ, 2009
That β agonists were still used for tocolysis in 2006-7, given their potentially serious side effects …
openaire +2 more sources
That β agonists were still used for tocolysis in 2006-7, given their potentially serious side effects …
openaire +2 more sources
The quality of randomised trials of tocolysis [PDF]
BJOG: An International Journal of Obstetrics & Gynaecology, 2006 Tocolytic treatment of suspected preterm labour has been evaluated in at least 75 randomised controlled trials. These have been included in six Cochrane reviews. If the trials are poorly designed, such reviews may mislead or, at best, provide weaker evidence than those based on well‐designed ones.
openaire +2 more sources
Tocolysis for management of retained placenta
2009Retained placenta affects 0.5% to 3% of women following delivery, with considerable morbidity if left untreated. Use of tocolytics, either alone or in combination with uterotonics, may be of value to minimise the need for manual removal of the placenta in theatre under anaesthesia.Evaluate the benefits and harms of tocolytics alone or in addition to ...
Hany Abdel-Aleem +2 more
openaire +2 more sources
Maintaining and repeating tocolysis: A reflection on evidence
Seminars in Perinatology, 2017It is inherent to human logic that both doctors and patients want to suppress uterine contractions when a woman presents in threatened preterm labor. Tocolysis is widely applied in women with threatened preterm labor with a variety of drugs. According to literature, tocolysis is indicated to enable transfer to a tertiary center as well as to ensure the
Elsa Lorthe +5 more
openaire +3 more sources
727: A comparison of magnesium tocolysis versus no tocolysis in patients who deliver preterm
American Journal of Obstetrics and Gynecology, 2007WHO DELIVER PRETERM CLINT CORMIER, DAVID F. LEWIS, GINA GOMEZ, MICHAEL LUCAS, LISA HOLLIER, University of Texas Health Science Center at Houston, Houston, Texas, Louisiana State University Health Sciences Center at Shreveport, Obstetrics and Gynecology, Shreveport, Louisiana OBJECTIVE: To evaluate whether magnesium sulfate tocolysis improves latency ...
Lisa M. Hollier +4 more
openaire +2 more sources